openPR Logo
Press release

Global Active Implantable Medical Devices Market growing at a 6.96% during the forecast period

Global Active Implantable Medical Devices Market growing at

Active Implantable Medical Devices (AIMD) is an active medical device intended to be introduced into the human body, either completely or partially, or through any medical intervention surgically or medically into a natural orifice and is intended to remain after the completion of the procedure. Some of the AIMD devices include implantable cardiac pacemakers, implantable defibrillators and cochlear implants.

Demand Scenario

The global active implantable medical devices market was USD 20.62 billion in 2018 and is estimated to reach USD 33.02 billion by 2025 at a CAGR of 6.96% during the forecast period.

Request a Report Sample with Toc and figures: https://www.trendsmarketresearch.com/report/sample/3906

Growth by Region

North America holds the largest market share with a share of more than 33% in 2018 owing to the technological advancements in developing new active implantable devices. Europe, on the other hand, stands at the second spot with a share of 28.4% due to frequent product launches and is expected to remain the same during the forecast period. However, Asia-Pacific region is anticipated to remain as the most promising growth opportunities to market players in the mere future due to the steady rise in Asian economies like countries such as China, India and South Korea and also due to the rise in investments by AIMD manufacturers.

Drivers vs Constraints

The market is mainly driven by growing ageing population; rising prevalence of cardiovascular and neurological devices, huge investments and funds in order to develop technologically advanced products as well as favorable reimbursement scenario for ENT procedures especially in developed countries are driving the growth of the market. However, the global active implantable medical devices market is curbed by regulatory hurdles in developed countries such as the U.S., rising of other emerging markets as well as a shortage of skilled professionals globally are expected to restrain the growth of AIMD market globally.

Request for discount on This Report at: https://www.trendsmarketresearch.com/report/discount/3906

Industry Trends and Updates

Boston Scientific Corporation has announced investment and acquisition option agreement with Millipede, Inc. and has purchased a portion of its outstanding shares for a total consideration of USD 90 million for the treatment of severe mitral regurgitation (MR) with the help of IRIS Transcatheter Annuloplasty Ring System developed by the company.

MED-EL USA has announced that U.S Food and Drug Administration has granted the company with the clearance for its new Bonebridge bone conduction hearing implant system and is widely considered as a breakthrough in bone conduction technology.

Browse more detail information about this report visit at: https://www.trendsmarketresearch.com/report/analysis/MBC/active-implantable-medical-devices-market

Related Report: https://www.trendsmarketresearch.com/report/analysis/GMD/global-pharmaceutical-and-cosmeticsglobal-and-china-biomedicine-market

Related Report: https://www.trendsmarketresearch.com/report/analysis/GMD/global-healthcare-exoskeletons-market

Contact Us:

One Vincent Square
Westminster, London SW1P 2PN
United Kingdom
Email: sales@trendsmarketresearch.com
Website: https://www.trendsmarketresearch.com

About Us:

we are a UK-based market intelligence company that operates out of its passion to help brands grow, discover, and transform. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Active Implantable Medical Devices Market growing at a 6.96% during the forecast period here

News-ID: 1851344 • Views:

More Releases from Global Active Implantable Medical Devices Market

Market Survey: Global Active Implantable Medical Devices Market Forecast 2025 - Medtronic Plc., Abbott Laboratories, Cochlear Ltd.
Market Survey: Global Active Implantable Medical Devices Market Forecast 2025 - …
Researchmoz added Most up-to-date research on "Active Implantable Medical Devices Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2017 - 2025" to its huge collection of research reports. Global Active Implantable Medical Devices Market: Overview Active Implantable Medical Devices are medical implantable devices like cochlear implants, implantable defibrillators, Implantable cardiac monitoring devices, implantable nerve stimulators, ventricular assist devices (VAD) and implantable cardiac pacemakers primarily used to detect, monitor,

More Releases for AIMD

NETA Auto's First Store in Western Asia Grandly Opens in Azerbaijan, Acceleratin …
China's new energy vehicle brand, NETA Auto, officially opened its sales center in Baku, the capital of Azerbaijan. The opening of this sales center marks NETA Auto's official entry into the Western Asia market. Partnering with the local automobile giant Group Motors, NETA Auto aims to provide consumers with high-quality smart electric vehicle experiences. Image: https://www.getnews.info/uploads/8b43b666ac02c3d5f3650266e1988b1e.jpg NETA Auto representatives and Group Motor representatives attended the event. The opening ceremony was held at Babk
Active Implantable Medical Devices Market Size Estimated to Reach $27.7 Billion …
The Active Implantable Medical Devices Market size is estimated to reach $27.7 Billion by 2025, growing at a CAGR of 7.9% during the forecast period 2020-2025. An active implantable medical device (AIMD) is any active medical device that is intended to be totally or partially introduced into the human body for diagnostic or therapeutic purposes, and which is intended to remain in place The increasing Burdon of neurological diseases cardiovascular
Europe Viscosupplementation Market - Emerging Growth By Top Players Sanofi S.A., …
Patients suffering from OA have a lower-than-normal concentration of HA in their joints. Injecting HA lubricates bones to move smoothly over each other. Viscosupplementation facilitates movement and reduces pain in the arthritic joint. It is often recommended when other nonsurgical treatment methods have failed to provide positive outcomes. Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint
Active Implantable Medical Devices Market 2020 Growth, Share, Trends & Forecast …
New York, March 4, 2020: The Active Implantable Medical Devices Market is expected to exceed more than US$ 31.0 Billion by 2024 at a CAGR of 7.5% in the given forecast period. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.),
The global active implantable medical devices market was USD 20.62 billion in 20 …
The authors of the Active Implantable Medical Devices Market Report have done extensive study of the global Active Implantable Medical Devices market keeping in mind the key aspects such as growth determinants, opportunities, challenges, restraints, and market developments. This analysis will enrich the ability of the companies involved in the global Active Implantable Medical Devices market to make precise decisions. The report also emphasizes on the current and future trends
Active Implantable Medical Devices Market a CAGR of 6.96% during the forecast pe …
Active Implantable Medical Devices (AIMD) is an active medical device intended to be introduced into the human body, either completely or partially, or through any medical intervention surgically or medically into a natural orifice and is intended to remain after the completion of the procedure. Some of the AIMD devices include implantable cardiac pacemakers, implantable defibrillators and cochlear implants. Demand Scenario The global active implantable medical devices market was USD 20.62 billion